May 2016 FDA Recall Drug by Taro Pharmaceuticals U.s.a., Inc.
D-0134-2017 - Subpotent Drug

This Class III drug recall was voluntarily initiated by Taro Pharmaceuticals U.s.a., Inc. on May 26, 2016 for the product Drug. The FDA reported the reason for recall as subpotent drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0134-2017

Reason for Recall
Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione.
Initiated
05-26-2016
Reported
11-16-2016
Quantity
17,100 kits

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Taro Pharmaceuticals U.S.A., Inc.
Kamedis BIO-HERBAL DANDRUFF CARE THERAPEUTIC 2-STEP DANDRUFF CARE SYSTEM - Kamedis Bio-Herbal Dandruff Care 0.1% PYRITHIONE ZINC, STEP 1 PRE-TREAT Concentrated Botanical Scalp Lotion (0.1% Pyrithione Zinc) 4.20 FL OZ (125mL) (NDC 51672-2126-0) and STEP 2 CLEANSE Concentrated Botanical Dandruff Shampoo (1.0% Pyrithione Zinc)(0.6.80 FL OZ (200 mL) (NDC 51672-2125-5), Distributed by: Taro Pharmaceuticals U.S.A, Inc. Hawthorne, NY 10532. NDC

Batch or Lot Expiration Information

Lot# : E601, E602, E603, E604, E608, E609 - Exp. September 2017; E610 E611, Exp. October 2017